|
BACH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.382600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.851400E-01 |
| Normal-vs-Stage2 |
5.496200E-01 |
| Normal-vs-Stage3 |
8.784000E-02 |
| Normal-vs-Stage4 |
3.649000E-01 |
| Stage1-vs-Stage2 |
4.802600E-01 |
| Stage1-vs-Stage3 |
5.925600E-02 |
| Stage1-vs-Stage4 |
2.043800E-01 |
| Stage2-vs-Stage3 |
2.419000E-01 |
| Stage2-vs-Stage4 |
5.159800E-01 |
| Stage3-vs-Stage4 |
7.726000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.314400E-01 |
| Normal-vs-AfricanAmerican |
3.929800E-01 |
| Normal-vs-Asian |
7.126000E-01 |
| Caucasian-vs-AfricanAmerican |
5.345800E-01 |
| Caucasian-vs-Asian |
7.500800E-01 |
| AfricanAmerican-vs-Asian |
9.071800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.866800E-01 |
| Normal-vs-Female |
1.890640E-01 |
| Male-vs-Female |
2.351200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.249200E-01 |
| Normal-vs-Extreme_Weight |
8.547000E-01 |
| Normal-vs-Obese |
1.040610E-01 |
| Normal-vs-Extreme_Obese |
2.742600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.361800E-01 |
| Normal_Weight-vs-Obese |
6.500200E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.753200E-01 |
| Extreme_Weight-vs-Obese |
5.971500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.523200E-01 |
| Obese-vs-Extreme_Obese |
1.368220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.578400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.084300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.228800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.573700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.717000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.154200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.976380E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.600300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.015200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.818000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.415000E-01 |
| Normal-VS-Type2 PRCC |
3.748600E-01 |
| Normal-VS-KIRP CIMP |
1.224000E-02 |
| Normal-VS-Unclassified PRCC |
1.956840E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.211700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.473930E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.797200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.841900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.628100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.775800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.881000E-01 |
| Normal-vs-N1 |
1.396250E-02 |
| Normal-vs-N2 |
9.578800E-01 |
| N0-vs-N1 |
6.503500E-03 |
| N0-vs-N2 |
8.121400E-01 |
| N1-vs-N2 |
2.735800E-01 |
|
|
